Staphylococcus felis C4 exhibits invitro antimicrobial activity against methicillin-resistant Staphylococcus pseudintermedius in a novel canine skin explant model.
Overview
Research
Identity
View All
Overview
abstract
BACKGROUND: Canine superficial pyoderma is a common bacterial skin infection of dogs, generally caused by Staphylococcus pseudintermedius. The C4 strain of Staphylococcus felis was recently discovered to have strong antimicrobial activity against S. pseudintermedius in mice. OBJECTIVES: We aimed to evaluate invitro if this antimicrobial activity was maintained using a novel canine skin explant model. MATERIALS AND METHODS: Punch biopsies (8mm) of skin from recently euthanised dogs were collected and placed into six-well plates on top of an agarose pedestal. RESULTS: Histological examination of the skin explants showed an intact dermal-epidermal organisation and a stratum corneum that was successfully colonised by S. pseudintermedius after topical application. The number of colony forming units of S. pseudintermedius showed a 2 log increase after 24h colonisation, indicating that the explant supported bacterial growth. By contrast, co-treatment with S. felis C4 live bacteria and its sterile protein product significantly reduced the growth of a methicillin-susceptible (ST540, p=0.0357) and a methicillin-resistant (MR) strain (ST71, p=0.0143) of S. pseudintermedius. No detectable bacteria were recovered from or visualised on skin 24h posttreatment with the S. felis C4 sterile protein product. CONCLUSIONS AND CLINICAL RELEVANCE: Using a novel canine explant model, we demonstrate that the S. felis C4 strain inhibits the growth of S. pseudintermedius and that it is a promising candidate for a new probiotic therapy to treat cutaneous infections caused by S. pseudintermedius, including MR strains.
